The company’s focus is the development of new cancer treatments and is researching and developing new precision medicines targeting critical DNA damage response mutations that are the hallmarks of many cancers.
top of page
Recent Posts
See AllUsing the platform powered by advanced AI algorithms, Rakovina can quickly analyze billions of molecular structures ..
The Company expects to submit the Type C meeting request by next week.
Revive is advancing the research and development of Bucillamine as a potential treatment for long COVID and medical countermeasures...
© 2023 Frontier Merchant Capital Group. All Rights Reserved.
bottom of page